리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:발행예정
페이지 정보:영문 193 Pages
한글목차
세계의 블로팅 시스템 시장은 2030년까지 16억 달러에 달할 전망
2024년에 12억 달러로 추정되는 세계의 블로팅 시스템 시장은 2024-2030년의 분석 기간에 CAGR 5.4%로 성장하며, 2030년까지 16억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석 대상이 된 부문의 하나인 제약·바이오테크놀러지 기업용 최종 사용 시장은 6.0%의 CAGR을 기록하며, 분석 기간 종료시점으로 7억 7,620만 달러에 달할 것으로 예측됩니다. 학술·연구기관용 최종 사용 부문의 성장률은 분석 기간에 5.5%의 CAGR로 추정되고 있습니다.
미국 시장은 3억 1,000만 달러로 추정되는 한편, 중국은 8.5%의 CAGR로 성장할 것으로 예측됩니다.
미국의 블로팅 시스템 시장은 2024년에 3억 1,000만 달러로 추정되고 있습니다. 세계 2위의 경제대국인 중국은 2024-2030년의 분석 기간에 CAGR 8.5%로 추이하며, 2030년까지 3억 7,920만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역 시장으로는 일본과 캐나다를 들 수 있으며, 각각 분석 기간 중 3.1%, 4.3%의 CAGR로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 3.8%의 CAGR로 성장할 것으로 전망되고 있습니다.
세계의 블로팅 시스템 시장 - 주요 동향과 촉진요인의 개요
분자생물학 연구에 블로팅 시스템이 필수적인 이유
블로팅 시스템은 분자생물학의 기초적인 툴로 DNA, RNA, 단백질 등의 생체분자를 검출하고 분석하는 데 중요한 역할을 합니다. 웨스턴 블로팅, 서던 블롯팅, 노던 블롯팅과 같은 기술을 통해 연구자들은 핵산과 단백질을 막에 전사 및 고정하여 복잡한 혼합물에서 특정 분자를 식별, 정량, 특성화할 수 있습니다. 이러한 시스템은 정밀한 분자 분석이 필수적인 유전자 연구, 진단, 신약 개발 등 다양한 용도에서 필수적입니다. 블로팅 시스템은 저농도의 분자를 고특이도, 고감도로 검출할 수 있는 능력을 가지고 있으며, 질병의 분자적 기전 규명 및 표적치료제 개발을 목표로 하는 연구자들에게 매우 유용하게 활용되고 있습니다.
기술 발전은 블로팅 시스템의 미래를 어떻게 형성하고 있는가?
블로팅 시스템 분야는 기술 발전에 따라 효율성, 감도, 처리 능력이 향상되어 빠르게 진화하고 있습니다. 자동화 블롯팅 시스템과 같은 혁신은 블롯팅 프로세스를 간소화하고 수작업을 줄이며 오류를 최소화함으로써 특히 고처리량 실험실에서 큰 이점을 가져다줍니다. 향상된 화학 발광 및 형광 검출 방법의 개발로 블롯팅 분석의 민감도가 크게 향상되어 미량의 표적 분자를 검출할 수 있게 되었습니다. 또한 디지털 이미징과 분석 소프트웨어의 통합을 통해 연구자들은 보다 정확하고 재현성 있는 데이터를 얻을 수 있으며, 결과 해석이 용이해졌습니다. 이러한 기술 발전으로 인해 블롯팅 시스템은 더욱 편리하고 효과적이며, 연구 및 임상 분야 모두에서 적용 범위가 넓어지고 있습니다.
블로팅 시스템 산업에 영향을 미치는 과제와 시장 역학은 무엇인가?
블로팅 시스템 시장은 다양한 과제와 역동적인 시장 역학의 영향을 받고 있습니다. 주요 과제 중 하나는 고감도, 고특이성을 구현하면서도 비용 효율적이고 사용하기 쉬운 시스템에 대한 수요입니다. 이에 따라 다양한 분야의 연구자들의 다양한 요구를 충족시킬 수 있는 보다 견고하고 사용자 친화적인 시스템 개발에 대한 기업의 투자 움직임이 가속화되고 있습니다. 또 다른 큰 과제는 질량분석법이나 차세대 시퀀싱과 같은 대체 기술과의 경쟁입니다. 이들은 높은 처리량과 다중 분석 능력을 제공합니다. 이러한 문제점에도 불구하고 블로팅 시스템은 확립된 프로토콜, 범용성, 그리고 연구자들 간의 깊은 친숙함 때문에 분자생물학의 기반 기술로서 그 지위를 유지하고 있습니다. 시장 역학은 또한 맞춤형 의료에 대한 수요 증가와 정밀 분자진단의 필요성에 의해 형성되고 있으며, 이는 첨단 블롯팅 기술의 채택을 지속적으로 촉진하고 있습니다.
블로팅 시스템 시장의 성장을 이끄는 요인은 무엇인가?
블로팅 시스템 시장의 성장은 단백질 및 핵산 분석에 블로팅 기술에 크게 의존하는 단백질체학 및 유전체학 연구에 대한 수요 증가 등 여러 요인에 의해 촉진되고 있습니다. 특히 암, 감염성 질환, 유전성 질환 등의 분야에서 생물의학 연구 범위가 확대됨에 따라 상세한 분자 수준의 지식을 제공할 수 있는 첨단 블롯팅 시스템의 필요성이 높아지고 있습니다. 또한 환자 시료의 정밀한 분자 특성 평가가 필요한 맞춤형 의료의 부상으로 인해 보다 진보된 블롯팅 기술의 채택이 촉진되고 있습니다. 고감도 검출법 및 자동화 시스템 개발과 같은 기술적 발전은 블롯팅 분석의 효율성과 광범위한 연구기관으로의 보급을 가능하게 하여 시장 성장을 더욱 가속화하고 있습니다. 또한 과학 연구에서 재현성과 정확성에 대한 중요성이 높아짐에 따라 신뢰할 수 있는 결과를 제공할 수 있는 고품질 블롯팅 시스템에 대한 수요가 증가하고 있습니다. 연구가 분자생물학의 한계를 계속 넓혀감에 따라 고급 및 다용도 블롯팅 시스템에 대한 수요가 더욱 증가하여 시장의 혁신과 확장을 주도할 것으로 예측됩니다.
부문:
최종사용자별(제약/바이오 기업, 학술/연구기관, 병원/진단검사실)
조사 대상 기업의 예
Advansta Inc.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
Cell Signaling Technology, Inc.
F. Hoffmann-La Roche AG
GE Healthcare
LI-COR, Inc.(LI-COR Biosciences)
Merck KgaA
PerkinElmer, Inc.
Thermo Fisher Scientific, Inc.
AI 통합
검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보를 혁신하고 있습니다.
Global Industry Analysts는 일반적인 LLM(거대 언어 모델)이나 산업 특화 SLM(소규모 언어 모델)에 대한 쿼리 방식에 의존하는 대신, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색엔진 조사, 그리고 방대한 양의 기업, 제품/서비스, 시장 데이터가 포함됩니다.
관세 영향 계수
이번 보고서에는 Global Industry Analysts가 예측한 본사 소재지, 생산기지, 수출입(완제품 및 OEM)에 따른 기업의 경쟁력 변화에 따라 지역 시장에 미치는 관세의 영향을 반영했습니다. 이러한 복잡하고 다면적인 시장 현실은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학을 통해 경쟁사들에게 영향을 미칠 것입니다.
목차
제1장 조사 방법
제2장 개요
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트
기타 중동
아프리카
제4장 경쟁
KSA
영문 목차
영문목차
Global Blotting Systems Market to Reach US$1.6 Billion by 2030
The global market for Blotting Systems estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Pharma & Biotech Companies End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$776.2 Million by the end of the analysis period. Growth in the Academic & Research Institutes End-Use segment is estimated at 5.5% CAGR over the analysis period.
The U.S. Market is Estimated at US$310.0 Million While China is Forecast to Grow at 8.5% CAGR
The Blotting Systems market in the U.S. is estimated at US$310.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$379.2 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.
Global Blotting Systems Market - Key Trends and Drivers Summarized
Why Are Blotting Systems Integral to Molecular Biology Research?
Blotting systems are fundamental tools in molecular biology, playing a critical role in the detection and analysis of biomolecules such as DNA, RNA, and proteins. Techniques like Western blotting, Southern blotting, and Northern blotting enable researchers to transfer and immobilize nucleic acids or proteins onto a membrane for further analysis, allowing for the identification, quantification, and characterization of specific molecules within a complex mixture. These systems are indispensable in various applications, including genetic research, diagnostics, and drug development, where precise molecular analysis is crucial. The ability of blotting systems to detect low-abundance molecules with high specificity and sensitivity makes them invaluable for researchers seeking to understand the molecular underpinnings of diseases and develop targeted therapies.
How Are Technological Advancements Shaping the Future of Blotting Systems?
The field of blotting systems is evolving rapidly, driven by technological advancements that are enhancing the efficiency, sensitivity, and throughput of these techniques. Innovations such as automated blotting systems are streamlining the blotting process, reducing manual labor and minimizing errors, which is particularly beneficial in high-throughput laboratories. The development of enhanced chemiluminescence and fluorescence detection methods has significantly improved the sensitivity of blotting assays, enabling the detection of even minute quantities of target molecules. Additionally, the integration of digital imaging and analysis software is providing researchers with more accurate and reproducible data, facilitating better interpretation of results. These technological improvements are making blotting systems more accessible and effective, thereby expanding their applications in both research and clinical settings.
What Challenges and Market Dynamics Are Influencing the Blotting Systems Industry?
The blotting systems market is influenced by a range of challenges and dynamic market forces. One of the key challenges is the need for systems that can deliver high sensitivity and specificity while being cost-effective and easy to use. This has driven companies to invest in the development of more robust and user-friendly systems that can meet the diverse needs of researchers across different fields. Another significant challenge is the competition from alternative technologies, such as mass spectrometry and next-generation sequencing, which offer high-throughput and multiplexing capabilities. Despite these challenges, blotting systems remain a staple in molecular biology due to their established protocols, versatility, and the deep-rooted familiarity of these techniques among researchers. Market dynamics are also shaped by the growing demand for personalized medicine and the need for precise molecular diagnostics, which continue to drive the adoption of advanced blotting technologies.
What Factors Are Driving the Growth of the Blotting Systems Market?
The growth in the blotting systems market is driven by several factors, including the increasing demand for proteomics and genomics research, which relies heavily on blotting techniques for the analysis of proteins and nucleic acids. The expanding scope of biomedical research, particularly in the fields of cancer, infectious diseases, and genetic disorders, is also fueling the need for advanced blotting systems that can provide detailed molecular insights. Additionally, the rise of personalized medicine, which requires precise molecular characterization of patient samples, is driving the adoption of more sophisticated blotting technologies. Technological advancements, such as the development of high-sensitivity detection methods and automated systems, are further propelling market growth by making blotting assays more efficient and accessible to a broader range of laboratories. Moreover, the increasing emphasis on reproducibility and accuracy in scientific research is enhancing the demand for high-quality blotting systems that can deliver reliable results. As research continues to push the boundaries of molecular biology, the need for advanced and versatile blotting systems is expected to grow, driving further innovation and expansion in the market.
SCOPE OF STUDY:
The report analyzes the Blotting Systems market in terms of units by the following Segments, and Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 44 Featured) -
Advansta Inc.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
Cell Signaling Technology, Inc.
F. Hoffmann-La Roche AG
GE Healthcare
LI-COR, Inc. (LI-COR Biosciences)
Merck KgaA
PerkinElmer, Inc.
Thermo Fisher Scientific, Inc.
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
Blotting Systems - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Demand for Protein Analysis Propels Growth of Blotting Systems
Advancements in Imaging Technologies Drive Adoption of Automated Blotting Systems
Rising Research in Proteomics Expands the Addressable Market Opportunity
Shift Towards High-Throughput Blotting Systems Strengthens the Business Case for Innovation
Growing Focus on Precision Medicine Throws the Spotlight on Advanced Blotting Techniques
Rising Incidence of Chronic Diseases Spurs Demand for Reliable Diagnostic Tools
Here's the Story: How Automation in Laboratories Drives Adoption of Blotting Systems
Integration of Blotting Systems with Digital Platforms Generates Competitive Advantages
Here's How Environmental and Food Safety Testing Spurs the Need for Efficient Blotting Systems
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Blotting Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Blotting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Hospitals & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 14: USA Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 15: USA Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 16: USA 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
CANADA
TABLE 17: Canada Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 18: Canada Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 19: Canada 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
JAPAN
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 20: Japan Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 21: Japan Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 22: Japan 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
CHINA
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 23: China Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 24: China Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 25: China 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
EUROPE
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 26: Europe Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 27: Europe Historic Review for Blotting Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 28: Europe 15-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 29: Europe Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 30: Europe Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 31: Europe 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
FRANCE
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 32: France Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 33: France Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 34: France 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
GERMANY
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 35: Germany Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 36: Germany Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 37: Germany 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
ITALY
TABLE 38: Italy Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 39: Italy Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 40: Italy 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
UNITED KINGDOM
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 41: UK Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 42: UK Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 43: UK 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
SPAIN
TABLE 44: Spain Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 45: Spain Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 46: Spain 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
RUSSIA
TABLE 47: Russia Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 48: Russia Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 49: Russia 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 51: Rest of Europe Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 52: Rest of Europe 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 54: Asia-Pacific Historic Review for Blotting Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 55: Asia-Pacific 15-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 57: Asia-Pacific Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 58: Asia-Pacific 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
AUSTRALIA
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 59: Australia Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 60: Australia Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 61: Australia 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
INDIA
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 62: India Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 63: India Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 64: India 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
SOUTH KOREA
TABLE 65: South Korea Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 66: South Korea Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 67: South Korea 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 69: Rest of Asia-Pacific Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
LATIN AMERICA
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 71: Latin America Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 72: Latin America Historic Review for Blotting Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 73: Latin America 15-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
TABLE 74: Latin America Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 75: Latin America Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 76: Latin America 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
ARGENTINA
TABLE 77: Argentina Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 78: Argentina Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 79: Argentina 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
BRAZIL
TABLE 80: Brazil Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 81: Brazil Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 82: Brazil 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
MEXICO
TABLE 83: Mexico Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 84: Mexico Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 85: Mexico 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 87: Rest of Latin America Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 88: Rest of Latin America 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
MIDDLE EAST
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 89: Middle East Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 90: Middle East Historic Review for Blotting Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 91: Middle East 15-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
TABLE 92: Middle East Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 93: Middle East Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 94: Middle East 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
IRAN
TABLE 95: Iran Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 96: Iran Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 97: Iran 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
ISRAEL
TABLE 98: Israel Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 99: Israel Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 100: Israel 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
SAUDI ARABIA
TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 102: Saudi Arabia Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 103: Saudi Arabia 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 104: UAE Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 105: UAE Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 106: UAE 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 108: Rest of Middle East Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 109: Rest of Middle East 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
AFRICA
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 110: Africa Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 111: Africa Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 112: Africa 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030